HCID 135526559, Verbindung → HCID 135899484, Verbindung
Reaktionsgleichung
[N:1]1(CCCC2N=[N+]([O-])C3C=C4C(CCC4)=CC=3[N+]=2[O-])[CH2:6]COC[CH2:2]1.N1(C[CH2:32][CH2:33][NH:34][C:35]2[N:36]=[N+:37]([O-:49])[C:38]3[CH:48]=[C:47]4[C:43]([CH2:44][CH2:45][CH2:46]4)=[CH:42][C:39]=3[N+:40]=2[O-:41])CCOCC1>>[CH2:33]([NH:34][C:35]1[N:36]=[N+:37]([O-:49])[C:38]2[CH:48]=[C:47]3[C:43]([CH2:44][CH:45]([N:1]([CH3:6])[CH3:2])[CH2:46]3)=[CH:42][C:39]=2[N+:40]=1[O-:41])[CH3:32]Komponenten
3
Versuchsvorschrift
More preferably, the compound of Formula I is 3-[3-(4-Morpholinyl)propyl]-7,8-dihydro-6H-indeno[5,6-e][1,2,4]triazine 1,4-Dioxide or N-[3-(4-Morpholinyl)propyl]-7,8-dihydro-6H-indeno[5,6-e][1,2,4]triazin-3-amine 1,4-dioxide.
Quellen und Nachweise
- ORD-Eintrag
- ord-478d5214b43d4803a1e1e0cbe58e2030
- Quelldatensatz
- uspto-grants-2011_08
- Patentnummer
- US07989451B2